Immortal cells and academia-industry collaboration

Experts insights about external innovation and collaboration

In this episode Dr. Collins talks about the differences of approaches of industry-academia collaboration, immortalization of cells and importance of commercialization for researchers. Dr. Daniel Collins has over 30 years of medical industry experience. He co-founded BioE, Inc. in 1993. Throughout the years Dr. Collins held various managing positions like director of R&D Systems, Inc.’s Flow Cytometry Products department; director of Coulter Corporation’s hematology lab within its Immunology division; and director of the Harrington Cancer Center’s Immunology, Hematology and Oncology specialty laboratory. Additionally, Dr. Collins was awarded a postdoctoral National Institutes of Health fellowship in tumor immunology at Wake Forest University.

 Have a question / trouble ?